drugset / Trial / NCT00878384

Catheter Ablation Versus Medical Rate Control for Atrial Fibrillation in Patients With Heart Failure

NCT00878384

RandomizedParallel-groupOpen-labelTreatment

Summary

It is still uncertain what the best treatment is for patients who have both atrial fibrillation (AF) and heart failure. The aim of the study is to help identify the optimal treatment for patients with these two significant medical conditions. This will be performed by comparing two alternative strategies for AF management: catheter ablation (to restore normal rhythm) and medical therapy (to control heart rate, but not aiming ro restore normal rhythm). After random assignment, the effect of each strategy will be assessed by looking for changes in exercise capacity, symptoms, heart pump function, and quality of life during 12 months of follow-up.

Timeline

Start
2009-04
Primary completion
2012-06
Completion
2012-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisoprolol Other / unclassified 1.25 mg
Comparator Bisoprolol Other / unclassified 20 mg
Comparator Carvedilol Other / unclassified 3.125 mg
Comparator Carvedilol Other / unclassified 50 mg
Comparator Digoxin Other / unclassified 62.5 ug
Comparator Digoxin Other / unclassified 250 ug
Comparator Nebivolol Other / unclassified 1.25 mg
Comparator Nebivolol Other / unclassified 10 mg